Literature DB >> 24132752

Di- and polynuclear silver(I) saccharinate complexes of tertiary diphosphane ligands: synthesis, structures, in vitro DNA binding, and antibacterial and anticancer properties.

Veysel T Yilmaz1, Elif Gocmen, Ceyda Icsel, Murat Cengiz, Sunde Y Susluer, Orhan Buyukgungor.   

Abstract

A series of new silver(I) saccharinate (sac) complexes, [Ag2(sac)2(μ-dppm)H2O]·H2O (1), {[Ag2(μ-sac)2(μ-dppe)]·3H2O·CH2Cl2} n (2), [Ag2(μ-sac)2(μ-dppp)] n (3), and [Ag(sac)(μ-dppb)] n (4) [dppm is 1,1-bis(diphenylphosphino)methane, dppe is 1,2-bis(diphenylphosphino)ethane, dppp is 1,3-bis(diphenylphosphino)propane, and dppb is 1,4-bis(diphenylphosphino)butane], have been synthesized and characterized by C, H, N elemental analysis, IR spectroscopy, (1)H NMR, (13)C NMR, and (31)P NMR spectroscopy, electrospray ionization mass spectrometry, and thermogravimetry-differential thermal analysis. Single-crystal X-ray studies show that the diphosphanes act as bridging ligands to yield a dinuclear complex (1) and one-dimensional coordination polymers (2 and 4), whereas the sac ligand adopts a μ2-N/O bridging mode in 2, and is N-coordinated in 1 and 4. The interaction of the silver(I) complexes with fish sperm DNA was investigated using UV-vis spectroscopy, fluorescence spectroscopy, and agarose gel electrophoresis. The binding studies indicate that the silver(I) complexes can interact with fish sperm DNA through intercalation, and complexes 1 and 3 have the highest binding affinity. The gel electrophoresis assay further confirms the binding of the complexes with the pBR322 plasmid DNA. The minimum inhibitory concentrations of the complexes indicate that complex 1 exhibits very high antibacterial activity against standard bacterial strains of Escherichia coli, Salmonella typhimurium, and Staphylococcus aureus, being much higher than those of AgNO3, silver sulfadiazine, ciprofloxacin, and gentamicin. Moreover, complexes 1-3 exhibit very high cytotoxic activity against A549 and MCF-7 cancer cell lines, compared with AgNO3 and cisplatin. The bacterial and cell growth inhibitions of the silver(I) complexes are closely related to their DNA binding affinities.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24132752     DOI: 10.1007/s00775-013-1052-y

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  40 in total

1.  Historical review of the use of silver in the treatment of burns. I. Early uses.

Authors:  H J Klasen
Journal:  Burns       Date:  2000-03       Impact factor: 2.744

2.  Anti-cancer activity of a novel palladium(II) complex on human breast cancer cells in vitro and in vivo.

Authors:  Engin Ulukaya; Ferda Ari; Konstantinos Dimas; Elif Ilkay Ikitimur; Emel Guney; Veysel T Yilmaz
Journal:  Eur J Med Chem       Date:  2011-08-05       Impact factor: 6.514

3.  Syntheses, structures, and antimicrobial activities of remarkably light-stable and water-soluble silver complexes with amino acid derivatives, silver(I) N-acetylmethioninates.

Authors:  Noriko Chikaraishi Kasuga; Rie Yoshikawa; Yoshitaka Sakai; Kenji Nomiya
Journal:  Inorg Chem       Date:  2012-01-20       Impact factor: 5.165

4.  The human pharmacology of silver sulphadiazine (AgSD)

Authors:  C L Fox
Journal:  Burns Incl Therm Inj       Date:  1985-04

5.  Cell death-inducing effect of novel palladium(II) and platinum(II) complexes on non-small cell lung cancer cells in vitro.

Authors:  Engin Ulukaya; Ferda Ari; Konstantinos Dimas; Mehmet Sarimahmut; Emel Guney; Nikos Sakellaridis; Veysel T Yilmaz
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-02       Impact factor: 4.553

6.  Mixed ligand-silver(I) complexes with anti-inflammatory agents which can bind to lipoxygenase and calf-thymus DNA, modulating their function and inducing apoptosis.

Authors:  C N Banti; A D Giannoulis; N Kourkoumelis; A M Owczarzak; M Poyraz; M Kubicki; K Charalabopoulos; S K Hadjikakou
Journal:  Metallomics       Date:  2012-05-03       Impact factor: 4.526

7.  catena-Poly[[(N,N-dimethylformamide-kappaO)(nitrato-kappaO)silver(I)]-mu-1,2-bis(diphenylphosphino)ethane-kappa(2)P:P'] at 100 and 293 K: temperature effects on the volume of the solvent pocket.

Authors:  Juliano R de Menezes Vicenti; Robert A Burrow
Journal:  Acta Crystallogr C       Date:  2007-02-10       Impact factor: 1.172

Review 8.  Bacterial silver resistance: molecular biology and uses and misuses of silver compounds.

Authors:  Simon Silver
Journal:  FEMS Microbiol Rev       Date:  2003-06       Impact factor: 16.408

9.  Plasmid mediated silver resistance in Acinetobacter baumannii.

Authors:  L M Deshpande; B A Chopade
Journal:  Biometals       Date:  1994-01       Impact factor: 2.949

10.  Bis[1,2-bis-(diphenyl-phosphino)ethane-κP:P']silver(I) bis-(chloro-difluoro-acetato-κO)(4-chloro-phen-yl)diphenyl-stannate(IV).

Authors:  Yin Yin Teo; Kong Mun Lo; Seik Weng Ng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-05-17
View more
  1 in total

1.  Ni(II), Cu(II), Mn(II), and Fe(II) Metal Complexes Containing 1,3-Bis(diphenylphosphino)propane and Pyridine Derivative: Synthesis, Characterization, and Antimicrobial Activity.

Authors:  Maged S Al-Fakeh; Gadah A Allazzam; Naeema H Yarkandi
Journal:  Int J Biomater       Date:  2021-07-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.